Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China
· Delayed Price · Currency is CNY 19.51
+0.06 (0.31%)
Apr 29, 2026, 3:00 PM CST
SHA:688553 Revenue
Sichuan Huiyu Pharmaceutical had revenue of 269.21M CNY in the quarter ending March 31, 2026, with 12.61% growth. This brings the company's revenue in the last twelve months to 1.03B, down -5.73% year-over-year. In the year 2025, Sichuan Huiyu Pharmaceutical had annual revenue of 998.14M, down -8.79%.
Revenue (ttm)
1.03B
Revenue Growth
-5.73%
P/S Ratio
8.00
Revenue / Employee
n/a
Employees
1,331
Market Cap
8.22B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KPC Pharmaceuticals,Inc. | 5.80B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.14B |
| Jiuzhitang | 2.23B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| Tianjin Ringpu Bio-Technology | 3.40B |
| Shandong Lukang Pharmaceutical | 5.71B |
| Jiangsu Kanion Pharmaceutical | 3.29B |
| Hunan Er-Kang Pharmaceutical | 1.06B |